BetaGlue Therapeutics

Description

Develops a localized radiotherapeutic platform delivering precise intratumoral radiation for durable local control; used for unresectable solid tumors and clinical pancreatic cancer studies.

Related

• Ability PharmaceuticalsAbilityPharma develops biopharmaceutical drug candidates. Its clinical pipeline targets cancer treatment, including ABTL0812 trials for…
• Iovance Biotherapeutics ($IOVA)Develops and manufactures tumor infiltrating lymphocyte therapies that use a patient’s immune cells, serving people with cancer and…
• ONK TherapeuticsONK Therapeutics develops ready-made natural killer cell therapies.
• Intelligent Therapeutics, Inc.Engineers antibodies and antibody-like molecules for treating solid tumors and rare autoimmune diseases, with pipeline work in companion…
• OriginBuilds maps of cancer biology in real tumors, capturing spatial gene expression and images to train clinical models and predict drug…
• ArsenalBioDevelops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity, with focus on…
• ADVACAM s.r.o.Builds radiation imaging cameras and detectors for noiseless, sensitive, and precise single-particle detection used across industries such…
• ONCOMATRYX BIOPHARMA SLOncomatryx develops biotechnology programs focused on modulating the tumor microenvironment.
• THERAPANACEABuilds AI-driven oncology software and platforms for clinical teams and cancer centers to support segmentation, planning, and adaptive…
• Faron Pharmaceuticals Ltd.Develops immunotherapies that leverage patients' immune systems for cancer treatment, serving clinical researchers and healthcare providers…
• Elekta ABElekta builds radiotherapy systems and workflows for adaptive radiotherapy, used by clinicians and cancer centers to deliver more precise,…
• Newronika SPABuilds an adaptive deep brain stimulation system that senses neural signals and adjusts therapy in real time; used by physicians to…